Brief: Calcimedica Announces Positive Topline Data From Phase 2B Carpo Trial Of Auxora™ In Acute Pancreatitis (AP)
27/06/2024 13:43
June 27 (Reuters) - CalciMedica Inc CALC.O :
* CALCIMEDICA ANNOUNCES POSITIVE TOPLINE DATA FROM PHASE 2B
CARPO
TRIAL OF AUXORA™ IN ACUTE PANCREATITIS (AP)
* CALCIMEDICA INC: PRIMARY OBJECTIVE OF TRIAL MET
* CALCIMEDICA INC: STATISTICALLY SIGNIFICANT DOSE RESPONSE
WITH UP
TO 61.7% REDUCTION IN SEVERE ORGAN FAILURE IN ALL PATIENTS
VERSUS PLACEBO
* CALCIMEDICA INC: PLANNING END-OF-PHASE 2 MEETING WITH FDA
Source text for Eikon: ID:nPn91Ml3sa
Further company coverage: CALC.O
((Reuters.Briefs@thomsonreuters.com;))